Exact Mass: 499.2066884
Exact Mass Matches: 499.2066884
Found 148 metabolites which its exact mass value is equals to given mass value 499.2066884
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tyr-Gly-Gly-Phe-Gly-OH
Ser His Gln Glu
Cys Lys Ser Tyr
C21H33N5O7S (499.21005880000007)
Cys Lys Tyr Ser
C21H33N5O7S (499.21005880000007)
Cys Ser Lys Tyr
C21H33N5O7S (499.21005880000007)
Cys Ser Tyr Lys
C21H33N5O7S (499.21005880000007)
Cys Tyr Lys Ser
C21H33N5O7S (499.21005880000007)
Cys Tyr Ser Lys
C21H33N5O7S (499.21005880000007)
Asp His Gln Thr
Asp His Thr Gln
Asp Gln His Thr
Asp Gln Thr His
Asp Thr His Gln
Asp Thr Gln His
Glu His Asn Thr
Glu His Gln Ser
Glu His Ser Gln
Glu His Thr Asn
Glu Asn His Thr
Glu Asn Thr His
Glu Gln His Ser
Glu Gln Ser His
Glu Ser His Gln
Glu Ser Gln His
Glu Thr His Asn
Glu Thr Asn His
Phe Gly Asn Tyr
Phe Gly Tyr Asn
Phe Asn Gly Tyr
Phe Asn Tyr Gly
Phe Tyr Gly Asn
Phe Tyr Asn Gly
Gly Phe Asn Tyr
Gly Phe Tyr Asn
Gly Asn Phe Tyr
Gly Asn Tyr Phe
Gly Tyr Phe Asn
Gly Tyr Asn Phe
His Asp Gln Thr
His Asp Thr Gln
His Glu Asn Thr
His Glu Gln Ser
His Glu Ser Gln
His Glu Thr Asn
His Asn Glu Thr
His Asn Thr Glu
His Gln Asp Thr
His Gln Glu Ser
His Gln Ser Glu
His Gln Thr Asp
His Ser Glu Gln
His Ser Gln Glu
His Thr Asp Gln
His Thr Glu Asn
His Thr Asn Glu
His Thr Gln Asp
Lys Cys Ser Tyr
C21H33N5O7S (499.21005880000007)
Lys Cys Tyr Ser
C21H33N5O7S (499.21005880000007)
Lys Ser Cys Tyr
C21H33N5O7S (499.21005880000007)
Lys Ser Tyr Cys
C21H33N5O7S (499.21005880000007)
Lys Tyr Cys Ser
C21H33N5O7S (499.21005880000007)
Lys Tyr Ser Cys
C21H33N5O7S (499.21005880000007)
Asn Glu His Thr
Asn Glu Thr His
Asn Phe Gly Tyr
Asn Phe Tyr Gly
Asn Gly Phe Tyr
Asn Gly Tyr Phe
Asn His Glu Thr
Asn His Thr Glu
Asn Thr Glu His
Asn Thr His Glu
Asn Tyr Phe Gly
Asn Tyr Gly Phe
Gln Asp His Thr
Gln Asp Thr His
Gln Glu His Ser
Gln Glu Ser His
Gln His Asp Thr
Gln His Glu Ser
Gln His Ser Glu
Gln His Thr Asp
Gln Ser Glu His
Gln Ser His Glu
Gln Thr Asp His
Gln Thr His Asp
Ser Cys Lys Tyr
C21H33N5O7S (499.21005880000007)
Ser Cys Tyr Lys
C21H33N5O7S (499.21005880000007)
Ser Glu His Gln
Ser Glu Gln His
Ser His Glu Gln
Ser Lys Cys Tyr
C21H33N5O7S (499.21005880000007)
Ser Lys Tyr Cys
C21H33N5O7S (499.21005880000007)
Ser Gln Glu His
Ser Gln His Glu
Ser Tyr Cys Lys
C21H33N5O7S (499.21005880000007)
Ser Tyr Lys Cys
C21H33N5O7S (499.21005880000007)
Thr Asp His Gln
Thr Asp Gln His
Thr Glu His Asn
Thr Glu Asn His
Thr His Asp Gln
Thr His Glu Asn
Thr His Asn Glu
Thr His Gln Asp
Thr Asn Glu His
Thr Asn His Glu
Thr Gln Asp His
Thr Gln His Asp
Tyr Cys Lys Ser
C21H33N5O7S (499.21005880000007)
Tyr Cys Ser Lys
C21H33N5O7S (499.21005880000007)
Tyr Phe Gly Asn
Tyr Phe Asn Gly
Tyr Gly Phe Asn
Tyr Gly Asn Phe
Tyr Lys Cys Ser
C21H33N5O7S (499.21005880000007)
Tyr Lys Ser Cys
C21H33N5O7S (499.21005880000007)
Tyr Asn Phe Gly
Tyr Asn Gly Phe
Tyr Ser Cys Lys
C21H33N5O7S (499.21005880000007)
Tyr Ser Lys Cys
C21H33N5O7S (499.21005880000007)
methyl 4-cyano-5-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-3-methyl-2-thenoate
C23H29N7O4S (499.20016340000006)
Ranolazine dihydrochloride
C24H35Cl2N3O4 (499.20044900000005)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[(1R,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C29H29N3O5 (499.21071040000004)
N-[(1S,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C29H29N3O5 (499.21071040000004)
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[(1R,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
C29H29N3O5 (499.21071040000004)
N-[(1S,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C29H29N3O5 (499.21071040000004)
N-[(1R,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C29H29N3O5 (499.21071040000004)
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
C26H33N3O5S (499.2140808000001)
N-[(1R,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C29H29N3O5 (499.21071040000004)
[3-methoxy-2-[methyl-[(E)-10,16,16-trichlorohexadec-4-enoyl]amino]propyl] acetate
C23H40Cl3NO4 (499.2022770000001)
Osteogenic Growth Peptide (10-14)
Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor[1][2][3][4].
methyl 1-{[7-(benzyloxy)-1,10-dimethoxyphenanthren-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate
C30H29NO6 (499.19947740000003)
methyl (2r)-1-{[7-(benzyloxy)-1,10-dimethoxyphenanthren-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate
C30H29NO6 (499.19947740000003)
(2r,4s)-2-[(1e)-2-(5,7-dimethoxy-2-oxochromen-8-yl)ethenyl]-6-methyl-4-(2-methylprop-1-en-1-yl)-2h,3h,4h-pyrano[3,2-c]quinolin-5-one
C30H29NO6 (499.19947740000003)
(2s)-3-methoxy-2-[(4e)-10,16,16-trichloro-n-methylhexadec-4-enamido]propyl acetate
C23H40Cl3NO4 (499.2022770000001)